(S) -DOTAGA. (SA.FAPi) 2
(S) -DOTAGA. (SA.FAPi) 2 is a precursor for radiopharmaceutical labeling, which can be combined with radionuclides to create radionuclide drug conjugates (RDCs) . RDCs have the capability to specifically target biomolecules and can be used in medical imaging[1].
Product Specifications
CAS Number
[2417089-06-4]
UNSPSC
12352203
Target
Radionuclide-Drug Conjugates (RDCs)
Type
Reference compound
Related Pathways
Antibody-drug Conjugate/ADC Related
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/s-dotaga-sa-fapi-2.html
Smiles
N#C[C@@H]1CC(F)(CN1C(CNC(C2=CC=NC3=C2C=C(C=C3)OCCCCNC4=C(C(C4=O)=O)NCCNC(CC[C@H](N5CCN(CCN(CCN(CC5)CC(O)=O)CCNC6=C(C(C6=O)=O)NCCCCOC7=CC8=C(N=CC=C8C(NCC(N9CC(F)(C[C@H]9C#N)F)=O)=O)C=C7)CC(O)=O)C(O)=O)=O)=O)=O)F
Molecular Formula
C71H83F4N17O17
Molecular Weight
1522.52
References & Citations
[1]Frank Rösch, et al. Marking precursor with square acid coupling. DE102018126558A1. 2020 April 30.
Shipping Conditions
Room temperature
Scientific Category
ADC Related
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
